The Future of Ketamine and Mood Disorders In 2019, the FDA and European Commission accepted using an esketamine nasal spready underneath the model name Spravato to deal with depression. Nonetheless, as of 2021, ketamine has not been authorised because of the FDA to deal with depression or other psychological wellness disorders, and thus, the medica